HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00
- £4.20bn
- £4.99bn
- $2.88bn
- 87
- 50
- 93
- 93
REG - Hikma Pharmaceutical - Board Committee Changes
AnnouncementRCS - Hikma Pharmaceutical - Hikma enters agreement to commercialise Ryaltris™
AnnouncementREG - Hikma Pharmaceutical - Final Results
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Notice of Results
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementRCS - Hikma Pharmaceutical - Hikma announces agreement with Chiesi Group
AnnouncementRCS - Hikma Pharmaceutical - Hikma announces agreement with Arecor
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementRCS - Hikma Pharmaceutical - Civica Rx and Hikma announce shipment of medicines
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Hikma completes FDA response for generic Advair®
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Block Listing Application
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
Announcement